Status:
COMPLETED
Analysis of Biological Progression and Regression of HELLP Syndrome in Time
Lead Sponsor:
CHU Mohammed VI Marrakech
Conditions:
HELLP Syndrome
Preeclampsia
Eligibility:
FEMALE
Brief Summary
Prospective observational study about progression and regression of biological parameters of HELLP syndrome
Detailed Description
Data collection included a comprehensive review of pathological histories, identification of complications based on clinical presentation, daily monitoring of biological parameters, documentation of t...
Eligibility Criteria
Inclusion Criteria:
- Pregnant women who are admitted to the maternal ICU for a biological HELLP syndrome
Exclusion Criteria:
- Patients whose biological presentation was attributable to other conditions, such as microangiopathies or leukemia.
- Patients who benefited from plasma exchange therapy
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2025
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06758960
Start Date
July 1 2023
End Date
August 31 2025
Last Update
March 31 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Mohammed VI of Marrakech
Marrakesh, Marrakesh-Safi, Morocco, 40000